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Background: Asthmatic children have been reported to complain about poor sleep 
quality. Recent research has demonstrated a relationship between sleep and circu-
lating cytokines. This study aimed to assess the relationship between serum cytokine 
levels and sleep quality in asthmatic children.
Methods: After an initial screening phase at allergy clinic visits, 90 asthmatic chil-
dren aged 6−12 years were enrolled to complete the Chinese version of the 
(Childhood) Asthma Control Test (ACT). A questionnaire assessing sleep quality of 
asthmatic children was also administered to all subjects and parents. We deter-
mined the serum levels of interleukin (IL)-4, IL-6, IL-10, IL-12, total immunoglobu-
lin (Ig) E, and prolactin at enrollment.
Results: Subjects with an ACT score ≥ 20 were assigned to the well-controlled group 
and those with a score of ≤ 19 were assigned to the inadequately controlled group. 
In the well-controlled group, good sleepers had a significantly lower mean level of 
IL-10 and a higher mean ratio of IL-12/IL-10 compared with the poor sleepers. 
Furthermore, the serum prolactin level was significantly greater in the good sleeper 
subgroup. In both subgroups, the concentrations of IL-6, IL-12 and total IgE were 
not significant different.
Conclusion: Good sleep is associated with a lower IL-10 level, a higher prolactin 
concentration, and a higher IL-12/IL-10 ratio. Prolactin may have a potential role 
in this immunity shift. Thus, further insight into the functional role of cytokines on 
the sleep quality of asthma sufferers will result in the identification of novel thera-
peutic perspectives.
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1. Introduction
Since publication of the results of the International 
Study of Asthma and Allergies in Childhood, the prev-
alence of asthma has shown a tendency to increase 
in Taiwan over the last 30 years.1 A recent national 
survey in Taiwan showed that the general hospi-
talization rate of children (< 18 years old) with 
asthma increased significantly between 1996 and 
2002.2 Many inflammatory mediators and cells play 
key roles in the development of the chronic proc-
esses of asthma, ultimately contributing to remod-
eling of the airway wall, resulting in a clinically 
heterogeneous phenotypic expression.3 In terms of 
the balance between TH1 and TH2 cells (helper 
T-cells, type 1 and type 2), allergic diseases are 
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well known as a TH2-dominant disorder. In recent 
years, there has been increasing recognition of the 
central role of TH2 cytokines, such as IL-4, IL-5 and 
IL-13, in the context of asthma. It is important to 
note that allergic airway inflammation might be in-
duced not only by an increased expression of TH2 cy-
tokines, but also by a decreased expression of 
counteracting cytokines such as IL-12 and inter-
feron gamma (IFN-γ). It has recently been shown that 
certain circulating hormones, such as prolactin, can 
influence the TH1/TH2 profile. For example, Lange 
et al demonstrated that high prolactin and low cor-
tisol levels contribute to the shift in the IL-12/IL-10 
ratio toward TH1 cytokine activity during sleep.4
We spend a third of our lives asleep. Circadian 
rhythms of various cytokines have been reported 
in both normal and sleep-deprived individuals; how-
ever, the exact functional role of each individual 
cytokine in the regulation of sleep remains to be 
fully established. There is an emerging body of ev-
idence from animal studies suggesting that sleep is 
closely intertwined with three classes of cytokines: 
TH1 cytokines (e.g. IFN-γ), anti-inflammatory/TH2 
cytokines (e.g. IL-10), and pro-inflammatory cy-
tokines (e.g. IL-6). Increased expression of pro-
inflammatory cytokines such as TNF, IL-6 and IL-1β 
can enhance sleep. By contrast, increased expres-
sion of anti-inflammatory cytokines such as IL-4 
and IL-10 can inhibit slow-wave sleep.5,6
Chronic diseases in children, such as asthma, may 
impair sleep quality and contribute to the devel-
opment of emotional problems both in the children 
and their families. Despite modern therapeutic ad-
vances, people with asthma often suffer sleep in-
terruption, caused either by the disease or by side 
effects of the medication. Even clinically stable 
asthmatic children report frequent nocturnal symp-
toms and sleep disturbances.7 Vir et al reported 
that more than 90% of young adults with clinically 
stable bronchial asthma had sleep disturbances.8 
Janson et al showed that difficulties inducing sleep 
and early morning awakenings were about twice as 
common, and daytime sleepiness was 50% more com-
mon, in asthmatic compared with non-asthmatic 
subjects.9 It has been proposed that a bidirectional 
relationship exists between sleep and behavioral/
emotional regulation. In a study of morbidity in 
nocturnal asthma, Fitzpatrick et al concluded that 
hospital outpatients with stable nocturnal asthma 
had impaired sleep quality and daytime cognitive 
performance.10 
The goals of asthma control in the 2006 global 
initiative for asthma (GINA) guidelines are for the 
patient to have no daytime or nocturnal symptoms 
and to have no limitations in daytime activities or 
social function.11 Despite the advances in treatment, 
the management of asthma for many patients is still 
discouraging, and the clinical effects disappear after 
medication is terminated. The level of asthma con-
trol is often overestimated by patients, caregivers 
and physicians, which indicates the need for an easy 
and practical tool to assess asthma control in addi-
tion to treatment guidelines. There is considerable 
evidence showing that both the Asthma Control Test 
(ACT) and the Childhood Asthma Control Test (C-ACT) 
are responsive to changes in specialist ratings of 
asthma control, the need for change in a patient’s 
therapy, and to clinically meaningful changes in the 
percentage of predicted FEV1.12,13 Therefore, we hy-
pothesized that well-controlled asthma would im-
prove sleep quality because the cytokine response 
may influence both sleep and asthma. The objec-
tives of the present study were to investigate the 
relationships among asthma control, cytokine levels 
and sleep quality of asthmatic children.
2. Materials and Methods
2.2. Study design
In this cross-sectional study, 90 asthmatic children 
were enrolled. They completed the (Childhood) 
Asthma Control Test (once) and a questionnaire to 
assess sleep quality. Peripheral blood samples were 
collected for laboratory analysis.
2.2. Study population
Potential subjects, ranging in age from 6 to 12 years, 
were invited from an allergy clinic of the Pediatrics 
Department of Tungs’ Taichung Metroharbor Hospital 
during a screening period. Subjects were eligible 
if they had a history of self-reported physician-
diagnosed asthma with current asthma-related symp-
toms for more than 6 months. All subjects were free 
of physical illness by examination, and none had a 
history of recent febrile infectious disease. Poten-
tial subjects using systemic glucocorticosteroids 
and bronchodilators (such as short-acting β2 adren-
ergic agonists), sleep medications, first-generation 
antihistamines or psychotropic medications were 
excluded from participating in this study. Second-
generation antihistamines were allowed for aller-
gic rhinitis. The Tungs’ Taichung Metroharbor Hospital 
Ethics Committee approved this study. Written in-
formed consent was obtained from each subject 
and from a parent or legal guardian of the eligible 
children.
2.3. Questionnaire and procedures
At the allergy clinic visit, we recorded characteris-
tics of all the subjects enrolled. A comprehensive 
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medical history was taken for eligible subjects, 
including any history of allergic diseases among 
family members and comorbid allergic diseases. A 
comprehensive physical examination, including 
measurement of body weight and height, was per-
formed. Body mass index (BMI) was calculated as 
weight (kg)/height (m2). 
According to their age, subjects either com-
pleted a Chinese version of the ACT (subjects > 11 
years old) or C-ACT (subjects aged 6−11 years old). 
Subjects with a score of ≥ 20 were assigned to the 
well-controlled group, and those with a score 
of ≤ 19 were assigned to the inadequately control-
led group. A self-rating questionnaire was adminis-
tered to assess sleep quality during the week prior 
to entering this study. The questionnaire is a three-
page, Chinese survey designed to assess the sub-
jective sleep quality in addition to collecting 
demographic information such as age, sex, school 
grades and comorbid allergic diseases. Parents and 
children were encouraged to answer the questions 
and to return the questionnaire. This Chinese ver-
sion of the questionnaire was designed to assess 
sleep quality of asthmatic school children and was 
found to have both high validity and high reliabil-
ity in a previous study (not published). Subjects 
were asked to score symptoms that they had expe-
rienced over the previous week. The questionnaire 
consists of 10 items corresponding to sleep distur-
bance and one to subjective sleep perception. The 
scores are indexed on a five-point scale for each 
item. Subjects rated the frequency of sleep distur-
bance as 0 (indicating none) to 4 (indicating daily) 
over the previous week. The possible scores range 
from 0 (no problems at all) to 40 (presence of all 
problems within the domain). A higher score indi-
cates greater sleep disturbance experienced by 
the subject during the previous week. In addition, 
the subjects were also asked to rate the level of 
subjective sleep perception, with 1 indicating very 
poor and 6 indicating very good, according to their 
actual sleep condition during the previous week. 
All subjects were able to finish the questionnaire 
within 20 minutes with or without help from 
parents. 
2.4. Blood sampling and laboratory tests
Peripheral blood samples were obtained by veni-
puncture from subjects at the start of the study. 
For each subject, 4 mL of blood was collected. The 
blood samples were then centrifuged, and the sera 
frozen immediately at −80ºC until thawed for later 
cytokine batch analysis. Each cytokine (IL-4, IL-6, 
IL-10 and IL-12) was quantified by enzyme-linked 
immunosorbent assay method with a high-sensitivity 
kit (R&D Systems, Minneapolis, MN, USA). The results 
were quantified against the standard curves gen-
erated using known amounts of recombinant cy-
tokines, according to the manufacturer’s instructions. 
The mean minimum detectable concentrations 
were 0.11 pg/mL and 0.039 pg/mL for IL-4 and IL-6, 
respectively. and 0.5 pg/mL for both IL-10 and 
IL-12. The intraassay coefficients of variation for 
all variables ranged 2.5−8.5%. All assays were per-
formed in duplicate, and the mean values were 
used for interpretation.The sera were also assayed 
for quantitative measurement of total immunoglob-
ulin E (IgE) level (IMMULITE® 2000 Total IgE assay, 
Diagnostics Products Corporation, USA). The limit of 
detection was 1 IU/mL. Quantitative measurement 
of serum prolactin was also performed (IMMULITE® 
2000 Prolactin Reagent, Diagnostics Products 
Corporation, USA), with an analytical sensitivity of 
0.16 ng/mL. 
2.5. Statistical analysis
All statistical analyses were performed using SPSS 
software (version 14.0 for Windows; SPSS Inc., 
Cary, NC, USA). Descriptive statistics were used for 
demographic characteristics. Inferential statistics 
were conducted on the scores of sleep quality and 
cytokine levels. Data are reported as means ± stand-
ard deviation. Because the scores for sleep quality 
and the sera level of cytokines were likely to be 
non-normally distributed, we used nonparametric 
tests for analyses. Intra-group comparisons were 
performed using the Wilcoxon rank sum test, and 
between-group comparisons were performed using 
the Mann-Whitney U test. A value of p < 0.05 indi-
cated a statistically significant difference.
3. Results
3.1.  Subjects and demographic
characteristics
Between June 2007 and December 2007, 90 sub-
jects (60 boys and 30 girls) were enrolled into this 
study. Table 1 summarizes the demographic char-
acteristics, severity of asthma, history of comorbid 
allergies and familial allergic diseases of the en-
rolled subjects. According to the ACT or C-ACT 
scores, there were 68 children categorized in the 
well-controlled group and 22 in the inadequately 
controlled group. The two groups did not differ 
significantly in terms of age, body weight, height 
or BMI. All of subjects in the well-controlled group 
had mild asthma, and 3 of the 22 subjects in the 
inadequately-controlled group had moderate per-
sistent asthma. The subjects in both groups had 
a high rate of comorbid allergic diseases (> 95%). 
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The majority (> 80%) of subjects had a positive 
family history of allergic diseases (e.g. asthma, al-
lergic rhinitis and atopic eczema).
3.2. Asthma control and laboratory tests
The first objective of this study was to examine 
sera cytokine levels in well-controlled and inade-
quately controlled asthmatic children. The means 
and standard deviations for each cytokine and the 
total IgE levels are presented in Table 2. Of the 
four cytokines measured, the level of IL-4 was neg-
ligible in the blood samples of 84 subjects and was 
excluded from further analysis. The TH1 (IL-12), 
anti-inflammatory/TH2 (IL-10), and pro-inflammatory 
(IL-6) cytokines were analyzed individually and as 
the ratio of IL-12/IL-10. The ratio of IL-12/IL-10 
reflects the relative balance between TH1/TH2 
cytokines, and affects the regulation of allergy. 
There were no significant differences in the sera 
levels of IL-6, IL-10, IL-12 and total IgE between 
the two groups, suggesting well-controlled asthma 
did not have a significant effect on the levels of 
cytokines or total IgE. Furthermore, there was no 
significant difference in the ratio of IL-12/IL-10 
between the two groups.
3.3. Asthma control and subjective sleep
 quality
The second objective was to investigate the rela-
tionship between subjective sleep quality and the 
level of asthma control in all subjects. A comparison 
of the two groups revealed that well-controlled 
asthmatic children had a significantly higher rating 
scale of subjective sleep perception. By contrast, 
Table 1 Demographic characteristics
 Well-controlled  Inadequately-controlled  Total 
 (n = 68) n (%) (n = 22) n (%) (n = 90) n (%)
Gender
 Male 43 (63.2%) 17 (77.3%) 60 (66.7%)
 Female 25 (36.8%) 5 (22.7%) 30 (33.3%)
Age (yrs) 8.88 ± 2.02 8.45 ± 2.2 8.78 ± 2.07
Height (cm) 132.79 ± 14.42 131.52 ± 15.7 132.48 ± 14.66
Weight (kg) 32.81 ± 11.14 34.06 ± 14.9 33.11 ± 12.09
BMI (kg/m2) 18.31 ± 3.11 18.87 ± 4.2 18.44 ± 3.38
Family history of allergy
 No 12 (17.6%) 3 (13.6%) 15 (16.7%)
 Yes 56 (82.4%) 19 (86.4%) 75 (83.3%)
Comorbid allergic diseases
 No 2 (2.9%) 1 (4.5%) 3 (3.3%)
 Yes 66 (97.1%) 21 (95.5%) 87 (96.7%)
Severity of asthma
 Grade 1 42 (61.8%) 6 (27.3%) 48 (53.3%)
 Grade 2  26 (38.2%) 13 (59.1%) 39 (43.3%)
 Grade 3 0 (0%) 3 (13.6%) 3 (3.3%)
Data are presented as means ± standard deviation; Grade 1 = intermittent; Grade 2 = mild persistent; Grade 3 = moderate 
persistent. BMI = body mass index.
Table 2 Asthma control and laboratory tests
 Inadequately-controlled (n =  22) Well-controlled (n =  68) p value
IL-6 (pg/mL) 1.43 ± 1.228 1.89 ± 4.084 0.460
IL-10 (pg/mL)  3.78 ± 3.494 3.57 ± 3.593 0.529
IL-12 (pg/mL) 0.77 ± 0.229 1.02 ± 0.788 0.081
IL-12/IL-10 0.34 ± 0.228 0.49 ± 0.547 0.108
IgE (IU/mL) 812.91 ± 734.542 922.99 ± 1,043.219 0.721
Data are presented as means ± standard deviation.
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both groups had similar values for sleep disturbance 
(Table 3).
3.4.  Subjective sleep quality and 
laboratory tests
The third objective was to examine the relation-
ship between subjective sleep quality and cytokine 
levels. There was no significant statistical correla-
tion between sleep disturbance and laboratory pa-
rameters in either group (data not shown). The 
subjects in the good sleeper subgroup were those 
who rated subjective sleep perception as 4, 5 or 6, 
while those who rated subjective sleep perception 
as 1, 2 or 3 were assigned to the poor sleeper sub-
group. In the inadequately controlled group, there 
were no significant differences in mean cytokine 
levels, IL-12/IL-10 ratio, or total IgE level between 
the two subgroups (data not shown). In the well-
controlled group, the mean IL-10 levels were sig-
nificantly lower in the good sleeper subgroup 
compared with the poor sleeper subgroup. There 
were no significant differences in IL-6, IL-12 or total 
IgE levels between the two subgroups (Figure). The 
IL-12/IL-10 ratio was significantly higher in the good 
sleeper subgroup compared with the poor sleeper 
subgroup. Furthermore, the sera prolactin level was 
significantly higher in the good sleeper subgroup 
compared with the poor sleeper subgroup. These 
findings suggest that better subjective sleep per-
ception was significantly associated with a reduced 
IL-10 level, a higher prolactin concentration, and a 
higher IL-12/IL-10 ratio.
4. Discussion
To the best of our knowledge, this is the first study 
to evaluate the relationship between subjective 
sleep quality and cytokine levels in well-controlled 
asthmatic children. Several important findings are 
of interest. First, as expected, well-controlled asth-
matic children had higher sleep quality than those 
with inadequately controlled asthma. Furthermore, 
this study demonstrated that the level of the TH2 
cytokine IL-10 was lower among good sleepers of 
asthmatic children with clinical stability. However, 
there were no statistically significant differences 
in individual IL-12 and IL-6 levels between the two 
subgroups. The mean ratio of IL-12/IL-10 was sig-
nificantly higher in good sleepers compared with 
poor sleepers. In addition, the good sleepers had a 
significantly higher sera prolactin level than the 
poor sleepers. Finally, there was no significant as-
sociation between the level of asthma control and 
the levels of cytokines measured here. Consistent 
with this finding, our analysis showed that the poor 
sleepers had higher TH2 cytokine activity, which 
will have a negative impact on asthma control.
Asthma is a frequently overlooked and misdiag-
nosed medical condition in young children. Proper 
management of asthma aims to improve health 
and well-being and reduce limitations in daily liv-
ing.11 However, clinicians often target the symp-
toms of asthma and comorbid allergies and do not 
consider the sleep disturbances suffered by the chil-
dren. Meanwhile, the sleep problems of children 
remain an area of asthma-related quality of life 
that is often neglected in both research and clini-
cal practice. Indeed, no treatment has been shown 
to improve sleep quality in patients with nocturnal 
asthma. In the Childhood Asthma Management 
Program, 351 of 1,041 (33.7%) children with rela-
tively stable asthma experienced one or more 
night awakenings caused by asthma during a 28-day 
screening period.14 Meanwhile, in the present study, 
57 of 68 (84.6%) subjects with well-controlled asthma 
reported poor sleep perception. These findings 
underscore that the asthma-related problems in 
Table 3 Asthma control and subjective sleep quality
 Inadequately-controlled (n =  22) Well-controlled (n =  68) p value
Sleep disturbance 8.14 ± 7.193 4.91 ± 4.203 0.063
Subjective sleep perception 3.95 ± 1.090 4.59 ± 1.149 0.028
Data are presented as means ± standard deviation.
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sleep represent an important aspect of quality of 
life for children with asthma. It is interesting to 
note that limitations in the sleep quality of chil-
dren, as with other limitations on quality of life, 
indicate that asthma is not well controlled. Pediatric 
clinicians, patients and parents or caregivers need 
to discuss sleep as part of asthma control assess-
ment. Further research needs to examine the risk 
factors for both asthma-related sleep quality and 
asthma control.
Individually, several cytokines have a role in 
both asthma and sleep regulation. Accumulating 
data suggest that allergic diseases are character-
ized by a predominant TH2 response to antigens. 
Lower IL-10 levels (TH2) may have benefits for 
asthma management. In vitro studies, in turn, 
have demonstrated that IL-10 can inhibit the ex-
pression of pro-inflammatory cytokines (IL-1, IL-6, 
IL-12 and TNF-α) by macrophages/monocytes.15−17 
These results indicate that IL-10 has anti-inflam-
matory activities and may act as a critical factor in 
allergic reactions. IL-10, IL-4 and IL-13 have been 
reported to inhibit spontaneous non-rapid eye 
movement sleep (NREMS). By contrast, other cy-
tokines such as IL-6, IL-18 and IFN-γ promote 
NREMS.18 These observations suggest that the role 
of IL-10 in inhibiting sleep skews the TH response 
toward TH2 dominance. In a pilot clinical study, 
Krouse et al failed to demonstrate any significant 
associations between sleep quality and the levels 
of cytokines assessed in their study, including IL-2, 
IL-4, IL-10 and IL-12, in patients with allergic rhin-
itis.19 For IL-6, this is difficult to explain. Total 
sleep deprivation has been shown to elevate cer-
tain inflammatory cytokines (IL-6 and TNF) in 
healthy young adults.20 In a study in which healthy 
young adults had sleep restricted to 6 hours per 
night, the 24-h production of IL-6 was enhanced.21 
These findings suggest that the daytime secretion 
of the pro-inflammatory cytokines IL-6 and TNF is 
increased after poor nocturnal sleep. Further re-
search regarding the roles of IL-6 and IL-12 in the 
sleep of asthmatic children might shed light on 
new strategies for asthma management.
The underlying mechanisms accounting for the 
association between sleep quality and alterations 
of immunity are currently not well known, but it is 
possible that sleep works through certain immuno-
logical and endocrine mediators. A study conducted 
by Born et al showed that nocturnal levels of the 
TH1 cytokines, such as IL-12 and IFN-γ, increase 
during sleep, with a decline in the production of 
these TH1 cytokines after sleep loss.22 However, 
the effect of sleep loss on the profile of TH2 cy-
tokines or the balance of TH1/TH2 cytokines in hu-
mans is not known. Previous studies have suggested 
that disordered sleep and sleep loss are associated 
with nocturnal elevations of sympathetic tone with 
increased production of norepinephrine and epineph-
rine.23,24 In an animal model, stress and the release 
of sympathetic neurotransmitters shifted the ex-
pression of TH cytokines toward a TH2-dominant 
profile.25 However, sympathetic neurotransmitters 
may not be the only neuroendocrine hormones that 
induce a cytokine shift; other candidates not ex-
amined in this study, including cortisol and growth 
hormone, may also be involved in this immunity 
shift. It is known that prolactin and growth hormone 
act synergistically to shift the TH1/TH2 balance to-
ward TH1 cytokine activity dominance, whereas 
cortisol and norepinephrine shift it toward TH2.26,27 
If these findings are replicated in a cohort with 
asthma, our present findings may provide limited 
help for the management of asthmatic children 
with sleep disturbance.
The chronic and acute inflammatory processes 
observed in the airways of atopic asthma can re-
sult from the excessive expression of cytokines, as 
has been observed in experimental induction of 
asthma by allergen challenge,28 or in the airways of 
symptomatic episodes.29 Nevertheless, there is no 
established evidence suggesting that ACT is re-
sponsive to cytokine change or the TH1/TH2 im-
mune response. Further clinical studies are needed 
to determine whether improved asthma manage-
ment, as assessed by ACT, predicts a shift in im-
mune profiles.
There are several limitations to the present study. 
First, an asthmatic population was exclusively stud-
ied because evidence suggests that people with 
asthma have decreased sleep quality compared 
with that of healthy controls. Thus, it is unknown 
whether differences in sleep quality and cytokine 
patterns can be generalized to healthy children. 
Second, because the study was cross-sectional in 
nature, a conclusion of causal relationships cannot 
be made. This study was also limited in its general-
izability to other patient populations. Further pro-
spective longitudinal studies are needed. Because 
the cytokine production in human whole blood ex-
hibits a circadian rhythm, more data should be ob-
tained with serial blood samplings during sleep. It 
is difficult and not ethical to collect large volumes 
of blood samples from young children, as is done in 
adult subjects. However, Krouse et al reported that 
serum cytokine levels (IL-1β, IL-1ra, IL-2, IL-4, IL-10 
and IL-12) measured five times overnight were rel-
atively stable in each sample collected from peo-
ple with allergic rhinitis.19 Another limitation is 
the lack of objective data (such as polysomnogra-
phy) on sleep, preventing us from fully describing 
the sleep architecture and assessing differences in 
sleep and asthma between the well-controlled and 
inadequately controlled subgroups. Finally, the exact 
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functional relationship of glucocorticosteroids and 
individual hormones, such as prolactin, in the en-
rolled asthmatic children may not be easy to pre-
dict, because it is difficult to accurately estimate 
the systemic loading of inhaled glucocorticoster-
oids in our patients due to adherence and the skill 
of inhalation. 
5. Conclusions
In conclusion, the main finding of the present study 
was that sleep quality in stable asthmatic children 
influences cytokine production and the TH1/TH2 
immunity balance. Therefore, identifying underly-
ing or comorbid sleep problems in children who 
present with inadequately controlled asthma is an 
important issue before deciding on a new strategy 
for asthma management (such as adding anti-
inflammatory agents or increasing the dosage of 
anti-inflammatory agents). Achieving good sleep 
can become a therapeutic option to enhance the 
success of managing diseases characterized by a 
TH2 cytokine predominance, such as atopic asthma. 
When considering a population-based public health 
approach to manage the increase in allergic dis-
eases, the lower economic and psychosocial costs 
of “good sleep” compared with prescription medi-
cations could provide a novel strategy for the 
healthcare of people with allergies. 
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